Intersect ENT prices its IPO low as biotech offerings start to wobble By: San Francisco Business Times via Business Journals July 24, 2014 at 09:02 AM EDT Intersect ENT Inc. priced its IPO at the low range of its target Thursday, selling 5 million shares at $11 each... Read More >> Related Stocks: Global Eagle Entrtn